Movicol Laranja

Polyethylene glycol 3350 with electrolytes, the active ingredient in Movicol Laranja, is an osmotic laxative presented as an oral solution for oral administration. It is indicated for the treatment of constipation, faecal impaction, and for bowel preparation prior to diagnostic procedures, and may be used in both adult and pediatric patients under medical supervision.

The product is manufactured for the EU market and meets European regulatory standards. GNH USA supplies Movicol Laranja as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Movicol Laranja, an osmotic laxative, works within the gastrointestinal tract to relieve constipation and related conditions.

- Constipation: Softens stool and facilitates regular bowel movements in patients with chronic or acute constipation. - Faecal impaction: Helps to break down hardened stool, allowing easier evacuation in cases of impaction. - Bowel preparation: Provides effective intestinal cleansing before colonoscopy or other diagnostic procedures.

Movicol Laranja may cause adverse reactions, which are generally mild but can include more serious events in rare cases.

Common Side Effects: - Abdominal bloating: sensation of fullness or swelling in the abdomen. - Nausea: mild feeling of queasiness. - Diarrhoea: loose or watery stools. - Flatulence: increased gas production.

Serious or Rare Side Effects: - Severe dehydration: marked loss of body fluids requiring medical attention. - Electrolyte imbalance: abnormal levels of sodium, potassium or chloride. - Allergic reaction: rash, itching, swelling, or difficulty breathing.

Before prescribing Movicol Laranja, clinicians should consider several precautionary measures to ensure safe use.

- Renal impairment: assess kidney function as reduced clearance may affect fluid balance. - Heart failure: monitor for fluid overload in patients with cardiac disease. - Electrolyte disorders: evaluate baseline sodium, potassium and chloride levels. - Pediatric use: adjust dosing and monitor growth in children under medical guidance. - Concomitant laxatives: avoid simultaneous use of other strong laxatives to prevent excessive fluid loss. - Store at ambient temperature: keep below 25 °C, retain in original container, protect from moisture and direct sunlight.

Movicol Laranja can interact with certain medicines, altering their effectiveness or safety profile.

Major Interactions (Avoid): - Diuretics: may increase risk of electrolyte disturbances when combined. - Antacids containing magnesium or aluminum: can reduce the osmotic effect of the solution. - Certain antibiotics (e.g., quinolones): may have reduced absorption if taken concurrently.

Moderate Interactions (Monitor Closely): - Oral rehydration salts: monitor electrolyte levels to avoid excess. - Blood pressure medications: observe for changes in blood pressure due to fluid shifts. - Other osmotic laxatives: combined use may cause severe diarrhoea.